Effects of direct and indirect activation of G protein of adenylyl cyclase on the subsequent response to β-adrenergic receptor agonists in human trachealis

被引:0
|
作者
Sudo, Y [1 ]
Kume, H [1 ]
Ito, S [1 ]
Ito, Y [1 ]
Yamaki, K [1 ]
Takagi, K [1 ]
机构
[1] Nagoya Univ, Sch Med, Dept Internal Med 2, Showa Ku, Nagoya, Aichi 4668560, Japan
来源
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 2002年 / 52卷 / 11期
关键词
airway smooth muscle; beta-adrenergic receptors; CAS; 949-36-0; 73573-87-2; formoterol; G protein and adenylyl cyclase; isoprenaline;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To examine the response to beta-adrenergic receptor agonists (beta-agonists) following prolonged activation of the stimulatory G protein of adenylyl cyclase (G(s)), relaxation by isoproterenol (isoprenaline, CAS 949-36-0) and formoterol (CAS 73573-872), a long-acting beta-agonist, after exposure to formoterol was measured in human tracheal smooth muscle, using isometric tension records. Prior exposure to formoterol (0.3-30 nmol/l) for 45 min reduced the subsequent relaxation induced by this drug in a concentration-dependent manner, but only modestly reduced that induced by isoproterenol. Next, the effects of cholera toxin (CTX, GAS 9012-63-9) an irreversible direct activator of G(s) and formoterol on the reduced responsiveness to isoproterenol after continuous and repeated exposure to isoprotenerol were examined. Preincubation with cholera toxin (0.02-2 mug/ml) caused concentration-dependent inhibition of the desensitization induced by isoproterenol, but preincubation with formoterol did not. These results indicate that prolonged activation of G(s) via beta-adrenergic receptors does not cause cross-desensitization to short-acting beta-agonists. However, it also fails to inhibit the desensitization of beta-adrenergic receptors after excessive exposure to short-acting beta-agonists. Activation of G(s) via a pathway that bypasses the receptors may be beneficial for the prevention of this phenomenon.
引用
收藏
页码:803 / 812
页数:10
相关论文
共 50 条
  • [1] Examination of the effects of increasing G(s) protein on beta(2)-adrenergic receptor, G(s), and adenylyl cyclase interactions
    Krumins, AM
    Barber, R
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) : 61 - 72
  • [2] Glucocorticoid effects on the β-adrenergic receptor-adenylyl cyclase system of human airway epithelium
    Aksoy, MO
    Mardini, IA
    Yang, Y
    Bin, W
    Zhou, SW
    Kelsen, SG
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (03) : 491 - 497
  • [3] Cannabinoid agonist signal transduction in rat brain: Comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition
    Breivogel, CS
    Childers, SR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (01): : 328 - 336
  • [4] Tubulin stimulates adenylyl cyclase activity in C6 glioma cells by bypassing the β-adrenergic receptor:: a potential mechanism of G protein activation
    Yan, K
    Popova, JS
    Moss, A
    Shah, B
    Rasenick, MM
    JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) : 182 - 190
  • [5] Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart
    Vatner, DE
    Asai, K
    Iwase, M
    Ishikawa, Y
    Shannon, RP
    Homcy, CJ
    Vatner, SF
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (12A): : 80H - 85H
  • [6] G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells
    Traish, AM
    Moreland, RB
    Gallant, C
    Huang, YH
    Goldstein, I
    RECEPTORS & SIGNAL TRANSDUCTION, 1997, 7 (02): : 121 - 132
  • [7] Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A(3) adenosine receptor
    Palmer, TM
    Harris, CA
    Coote, J
    Stiles, GL
    MOLECULAR PHARMACOLOGY, 1997, 52 (04) : 632 - 640
  • [8] INCREASED MUSCARINIC RECEPTOR-MEDIATED ADENYLYL CYCLASE INHIBITION AND G-PROTEIN ACTIVATION AS A MECHANISM OF ISCHEMIC PRECONDITIONING
    NIROOMAND, F
    BANGERT, M
    PHILIPPS, C
    RAUCH, B
    CIRCULATION, 1992, 86 (04) : 30 - 30
  • [9] The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase
    Yuan, YP
    Schoenwaelder, SM
    Salem, HH
    Jackson, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) : 27090 - 27098
  • [10] Potency and efficacy of partial agonists of the adenosine A(1) receptor in G protein activation and inhibition of adenylate cyclase.
    Lorenzen, A
    Vogt, H
    vanderWenden, EM
    Roelen, HCPF
    Carnielli, M
    Ijzerman, AP
    Schwabe, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 110 - 110